Koichi Amano

Oct 16, 2024 | asahi.com | Koichi Amano

NAGASAKI--Diet books often warn readers: “Eat at night, and you will gain weight.” That principle is exactly what a researcher in the prefectural capital is hoping to turn into an advantage by drawing on it to raise fatty fish in short periods of time. Katsuya Hirasaka, a professor at the Nagasaki University Faculty of Fisheries who studies chrono-nutrition, is behind the unconventional study.

Sep 12, 2024 | asahi.com | Koichi Amano

NAGASAKI—A team of researchers here has captured astonishing X-ray footage of young eels making a dramatic, Houdini-like escape from the stomach of a large predatory fish. After being swallowed whole, these resilient eels actively resist digestion and slither their way back up the predator’s gullet to freedom. The study, published in the Sept.

Jun 3, 2024 | asahi.com | Koichi Amano

SHIMABARA, Nagasaki Prefecture--A paper-craft model of Shimabara Castle here was released in April to mark its 400th anniversary. Construction of the historic structure, considered to be one of Japan’s top 100 castles, started in 1618 and finished several years later. It was built by the warlord Matsukura Shigemasa. The castle’s five-story tower was built without triangle-shaped “hafu” gables, which typically adorn castles of the period.

Dec 8, 2023 | asahi.com | Koichi Amano

ISAHAYA, Nagasaki Prefecture--On a recent day, the completion ceremony of an artwork commissioned by a Buddhist priest was held at the long-established Tenyuji temple in the Nishi-Kojimachi district here. Featured in the work is an unusual image added to the iconic Madonna and Child painting. In it, the mother of Jesus is portrayed as the Kannon bodhisattva, a Buddhist deity. Tetsujo Suda, chief monk of Tenyuji, conceived of the artwork featuring not only his own faith but also Christianity.

Apr 1, 2023 | rmdopen.bmj.com | Yusuke Miyazaki |Koichi Amano |Kiyoshi Matsui |Satoshi KUBO

Statistical analysisThe data analysis plan is described in the online supplemental information. Briefly, the study was powered to detect a 10% difference in sustained remission rates at week 104 between the tofacitinib and MTX discontinuation groups.